Bank of Montreal
ELOX

Bank of Montreal’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Bank of Montreal’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-22
Closed -$3K – 5328
2021
Q1 		$3K Sell
22
-84
-79% -$12.8K ﹤0.01% 4874
2020
Q4 		$18K Buy
106
+74
+231% +$9.04K ﹤0.01% 4473
2020
Q3 		$3K Sell
32
-24
-43% -$2.88K ﹤0.01% 4611
2020
Q2 		$6K Buy
56
+54
+2,700% +$6.11K ﹤0.01% 4394
2020
Q1 		$0 Sell
2
-79
-98% -$12.9K ﹤0.01% 4918
2019
Q4 		$23K Buy
81
+24
+42% +$4.84K ﹤0.01% 4254
2019
Q3 		$10K Buy
57
+8
+16% +$2.28K ﹤0.01% 4436
2019
Q2 		$20K Buy
49
+47
+2,350% +$19.8K ﹤0.01% 4187
2019
Q1 		$1K Sell
2
-8
-80% -$3.89K ﹤0.01% 4234
2018
Q4 		$5K Buy
10
+5
+100% +$2.76K ﹤0.01% 4115
2018
Q3 		$4K Hold
5
– – ﹤0.01% 4190
2018
Q2 		$4K Buy
+5
New +$3.24K ﹤0.01% 4204

Other funds holding ELOX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bank of Montreal's ELOX Position: Q2 2021 in Review

Bank of Montreal sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q2 2021, closing a stake of 22 shares — an estimated $3K sold.

Bank of Montreal first reported a position in ELOX in Q2 2018 and held it in 12 quarters. The position peaked at $23K in Q4 2019. 46 funds tracked by Wall St. Rank hold ELOX as of Q2 2021.

  • Bank of Montreal reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 22 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $3K.
  • Bank of Montreal first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 12 quarters.
  • Bank of Montreal's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $23K in Q4 2019.
  • 46 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.